Patent · US Active

Compounds and methods for the treatment of COVID-19

US11926642B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Robert Steven Kania · Del Mar, US
Padmavani Bezawada · Vernon Hills, US
Emma Louise Hawking · Deal, GB
Rohit Jaini · Chicago, US
Samir Kulkarni · East Lyme, US
Matthew Nathan O'Brien Laramy · Evanston, US
Jonathan Richard Lillis · Sandwich, GB
Suman Luthra · Groton, US
Dafydd Rhys Owen · Concord, US
Klimentina Dimitrova Pencheva · Sandwich, GB
Anil Mahadeo Rane · Mystic, US
Matthew Forrest Sammons · Quincy, US
Bradley Paul Sullivan · Gurnee, US
Andrew John Thiel · Gurnee, US
Martyn David Ticehurst · Wingham, GB
Jamison Bryce Tuttle · Pasadena, US
Robert Louis Hoffman · Kalamazoo, US

Key dates

Filing date	Jul 1, 2021
Grant date	Mar 12, 2024
Priority date	—
Expiry date	Sep 5, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to compounds of formula I wherein R1, R2 and - - - - - are as defined herein, pharmaceutical compositions comprising the compounds and methods of treating COVID-19 in a patient by administering therapeutically effective amounts of the compounds and methods of inhibiting or preventing replication of SARS-CoV-2 with the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.